Protagenic Therapeutics competitorsClear all

Protagenic Therapeutics's top competitors include Biogen, Inovio Pharmaceuticals, MyoKardia and Otonomy.
Protagenic Therapeutics
Protagenic Therapeutics
Protagenic Therapeutics is a biotechnology company focusing on developing natural human brain hormones to treat mood disorders.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Founding Date
Founding Date
1994
Founding Date
1978
Founding Date
1979
Founding Date
2012
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Whitchurch Stouffville, CA
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
Mississauga, CA
see more
Locations
Blue Bell, US HQ
San Diego, US
San Diego, US
Locations
South San Francisco, US HQ
Locations
San Diego, US HQ
Employees
Employees
41
Employees
7,8007% increase
Employees
2811% increase
Employees
1024% increase
Employees
498% decrease
Valuation ($)
Valuation ($)
18 m
Valuation ($)
44.3 b
Valuation ($)
244.1 m
Valuation ($)
2.2 b
Valuation ($)
73.6 m
Twitter followers
Twitter followers
N/A
Twitter followers
26.4 k
Twitter followers
1.9 k
Twitter followers
619
Twitter followers
233
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
48
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
24.9
Average likes per tweet (last 30 days)
11
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
83540
Alexa Website Rank
1151286
Alexa Website Rank
337057
Alexa Website Rank
691980

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
$30.5m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$745k (FY, 2018)
Net income
Net income
($2.6m) (FY, 2018)
Net income
$3.7b (FY, 2016)
Net income
($97m) (FY, 2018)
Net income
($67.7m) (FY, 2018)
Net income
($50.4m) (FY, 2018)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
620 (FY, 2016)
Patents Issued
N/A
Patents Issued
88 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2017)
Phase I Trials Products
1 (FY, 2016)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
2 (FY, 2016)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Preclinical Phase Products
Preclinical Phase Products
N/A
Preclinical Phase Products
N/A
Preclinical Phase Products
N/A
Preclinical Phase Products
3 (FY, 2017)
Preclinical Phase Products
1 (FY, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 63.3m
Total funding raised
$ 98m
Total funding raised
$ 153.4m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,800↑ 7% increase

Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
Inovio Pharmaceuticals
HQ
Blue Bell, US
Employees
281↑ 1% increase

Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Otonomy
HQ
San Diego, US
Employees
49↓ 8% decrease

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company